Chinese court fines GlaxoSmithKline almost $500 million for paying bribes
A Chinese court imposed a fine of nearly $500 million on the giant British pharmaceutical company GlaxoSmithKline for bribery, according to a New York Times report Friday. Image/CIA The fine of a record 3 billion More...
Flu shots: GSK begins shipping of 2014-15 U.S. flu vaccines, FLUARIX® QUADRIVALENT sent to U.S. healthcare providers
GlaxoSmithKline (GSK) announced today it has begun shipping FLUARIX®QUADRIVALENT (Influenza Vaccine) doses to U.S. healthcare providers. This is the first shipment of GSK’s U.S. flu vaccine supply for the flu More...
Diabetes drug, Tanzeum, receives FDA approval
PRESS RELEASE The U.S. Food and Drug Administration Tuesday approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Type More...
GlaxoSmithKline to supply HHS with 60,000 doses of raxibacumab, anthrax antitoxin
The US Department of Health and Human Services (HHS) has announced today the nation’s supply of anthrax antitoxin will be maintained until 2018 under Project BioShield contracts issued by the U.S. Department of More...
FDA approves FluLaval Quadrivalent influenza vaccine for persons three years and older
Pharmaceutical, biologics and vaccine company, GlaxoSmithKline (GSK), announced Friday that the Food and Drug Administration (FDA) has approved FluLaval Quadrivalent influenza vaccine for the active immunization More...
FDA approves Tivicay, a new drug to treat HIV-1 infection
PRESS RELEASE The U.S. Food and Drug Administration today approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes More...
Breo Ellipta receives FDA approval for the treatment of COPD
According to the National Heart, Lung and Blood Institute, chronic obstructive pulmonary disease (COPD) is a major cause of disability, and it’s the third leading cause of death in the United States. Currently, More...
GlaxoSmithKline’s Fluarix Quadrivalent receives FDA approval
CDC/ Debora Cartagena The first intramuscular vaccine to cover against four influenza strains has just received US Food and Drug Administration (FDA) approval, according to a GlaxoSmithKline (GSK) press release More...
FDA approves Promacta to treat low platelet counts in hepatitis C patients
The U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based More...
